In clinical studies, it has been administered in doses between 0.5mcg/kg and roughly 16,000mcg/kg for up to 2 weeks [42, 43]
Who might it not be right for Pregnant or breastfeeding individuals (data very limited)
Handling & Disclaimer FOR RESEARCH USE ONLY
Advantages: Localized delivery to target tissue (skin, scalp) Non-invasive Lower systemic exposure Well-tolerated with established safety record in cosmeceuticals Limitations: Limited dermal penetration (molecular weight ~340 Da near the cutoff for transdermal absorption) No systemic anti-aging or anti-inflammatory effects Efficacy dependent on formulation vehicle (liposomal carriers significantly improve penetration) GHK-Cu Injection (Subcutaneous) GHK-Cu injection is explored in research settings for systemic administration
ESHRE guideline: Management of women with endometriosis
Gut-brain axis support: Because BPC-157 is derived from gastric juice, it has particularly strong effects on gut lining repair, intestinal anastomoses, and enteric nervous system signaling